News
Resources
Blog
Sites
How research evolves and brings new hope to patients
By Stephen J. Ubl | June 11, 2021
Before medicines can be made available to patients, they often begin as ideas that are based on newly discovered molecules and cells, strange phenomena or little-understood processes in the body....
Read More
Continued R&D into Alzheimer’s disease means hope for patients, families and caregivers
By Richard Moscicki, M.D. | June 4, 2021
More than 6 million Americans, most of them age 65 or older, live with Alzheimer’s disease, a devastating degenerative brain disease and the most common form of dementia. After heart disease and...
Read More
Guest Post: Honoring Hispanic Heritage Month by taking action on health equity
By Guest Contributor | October 12, 2020
Conversations and healthy debate about issues facing our industry and the health care system are critical to addressing some of today’s challenges and opportunities. Today, we are pleased to...
Read More
Speaker Pelosi’s drug pricing plan could result in 56 fewer new medicines over 10 years
By Juliet Johnson | November 21, 2019
A new analysis from economic consulting firm Vital Transformation shows that Speaker Nancy Pelosi’s drug pricing plan, H.R.3, could result in at least 56 fewer innovative medicines for patients...
Read More
New report details the setbacks and challenges to Alzheimer’s research
By Gretta Stone | September 12, 2018
Illustrating the challenges of developing medicines to fight Alzheimer’s disease, a new analysis found that between 1998 and 2017, there were 146 unsuccessful medicines in clinical trials for...
Read More
Disrupting Alzheimer's
By Andrew Powaleny | September 10, 2018
We are living in a new era of medicine, where treatments and even cures once believed to be impossible are today a reality. But this immense progress does not apply universally and there have been...
Read More
A new era in Alzheimer’s innovation
By Andrew Powaleny | April 19, 2018
After heart disease and cancer, Alzheimer’s disease and dementia are the leading cause of death for seniors, responsible for one out of every three deaths. Today, the disease devastates the minds...
Read More
New report shows over 500 medicines in development for neurological disorders
By Andrew Powaleny | April 18, 2018
Neurological disorders, which include more than 1,000 conditions that disrupt the brain and nervous system, affect an estimated 100 million Americans, nearly one third of the U.S. population....
Read More
ICYMI – Report highlights increasing prevalence for Alzheimer’s disease
By Andrew Powaleny | December 11, 2017
The number of Americans affected by Alzheimer’s disease (AD) continues to rise according to a new report.1 Researchers found that approximately 6.08 million Americans had Alzheimer’s or mild...
Read More
Profiles in courage: Latinos in the fight against Alzheimer’s
By Guest Contributor | September 28, 2017
Conversations and healthy debate about issues facing our industry and the health care system are critical to addressing some of today’s challenges and opportunities. The Catalyst welcomes guest...
Read More
Medicare Monday (100)
340B Spotlight (46)
Cost & Consequence (0)
